Showing 1 - 5 results of 5 for search 'Clare R Sander', query time: 0.03s Refine Results
  1. 1
    Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.

    Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A. by Kathryn T. Whelan, Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Adrian V. S. Hill, Helen McShane

    Published 2011-01-01
    Get full text
    Article
  2. 2
    Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.

    Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A. by Kathryn T Whelan, Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton, Nicola C Alder, Adrian V S Hill, Helen McShane

    Published 2009-06-01
    Get full text
    Article
  3. 3
    Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.

    Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A. by Kristin L Griffiths, Ansar A Pathan, Angela M Minassian, Clare R Sander, Natalie E R Beveridge, Adrian V S Hill, Helen A Fletcher, Helen McShane

    Published 2011-01-01
    Get full text
    Article
  4. 4
    Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.

    Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials. by Ansar A Pathan, Clare R Sander, Helen A Fletcher, Ian Poulton, Nicola C Alder, Natalie E R Beveridge, Kathryn T Whelan, Adrian V S Hill, Helen McShane

    Published 2007-10-01
    Get full text
    Article
  5. 5
    Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials.

    Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials. by Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher, Ian Poulton, Nicola C. Alder, Natalie E. R. Beveridge, Kathryn T. Whelan, Adrian V. S. Hill, Helen McShane

    Published 2011-01-01
    Get full text
    Article

Search Tools: